Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease

Sikorska, Marianna; Lanthier, Patricia; Miller, Harvey; Beyers, Melissa; Sodja, Caroline; Zurakowski, Bogdan; Gangaraju, Sandhya; Pandey, Siyaram; Sandhu, Jagdeep K.

doi:10.1016/j.neurobiolaging.2014.03.032

Cited by 70Coenzyme Q10 studies and effectsParkinson's Disease Mechanisms and TreatmentsNanoparticle-Based Drug Delivery

Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease

Open access

Sikorska, Marianna, Lanthier, Patricia, Miller, Harvey, Beyers, Melissa, Sodja, Caroline, Zurakowski, Bogdan, Gangaraju, Sandhya, Pandey, Siyaram +1 more·2014·Neurobiology of Aging

DOI 10.1016/j.neurobiolaging.2014.03.032PMC PMC4892899

Open this paper in CoChat — free account

Abstract

Although the support for the use of antioxidants, such as coenzyme Q(10) (CoQ(10)), to treat Parkinson's disease (PD) comes from the extensive scientific evidence, the results of conducted thus far clinical trials are inconclusive. It is assumed that the efficacy of CoQ(10) is hindered by insolubility, poor bioavailability, and lack of brain penetration. We have developed a nanomicellar formulation of CoQ(10) (Ubisol-Q(10)) with improved properties, including the brain penetration, and tested its effectiveness in mouse MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) model with the objectives to assess its potential use as an adjuvant therapy for PD. We used a subchronic MPTP model (5-daily MPTP injections), characterized by 50% loss of dopamine neurons over a period of 28 days. Ubisol-Q(10) was delivered in drinking water. Prophylactic application of Ubisol-Q(10), started 2 weeks before the MPTP exposure, significantly offset the neurotoxicity (approximately 50% neurons died in MPTP group vs. 17% in MPTP+ Ubisol-Q(10) group by day 28). Therapeutic application of Ubisol-Q(10), given after the last MPTP injection, was equally effective. At the time of intervention on day 5 nearly 25% of dopamine neurons were already lost, but the treatment saved the remaining 25% of cells, which otherwise would have died by day 28. This was confirmed by cell counts, analyses of striatal dopamine levels, and improved animals' motor skill on a beam walk test. Similar levels of neuroprotection were obtained with 3 different Ubisol-Q(10) concentrations tested, that is, 30 mg, 6 mg, or 3 mg CoQ(10)/kg body weight/day, showing clearly that high doses of CoQ(10) were not required to deliver these effects. Furthermore, the Ubisol-Q(10) treatments brought about a robust astrocytic activation in the brain parenchyma, indicating that astroglia played an active role in this neuroprotection. Thus, we have shown for the first time that Ubisol-Q(10) was capable of halting the neurodegeneration already in progress; however, to maintain it a continuous supplementation of Ubisol-Q(10) was required. The pathologic processes initiated by MPTP resumed if supplementation was withdrawn. We suggest that in addition to brain delivery of powerful antioxidants, Ubisol-Q(10) might have also supported subcellular oxidoreductase systems allowing them to maintain a favorable cellular redox status, especially in astroglia, facilitating their role in neuroprotection. Based on this data further clinical testing of this formulation in PD patients might be justifiable.

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2014.03.032

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Coenzyme Q10 offers neuroprotection in animal models of neurodegenerative diseases such as Parkinson's disease.
“Furthermore, CoQ10 offers neuroprotection in animal models of neurodegenerative diseases (e.g. Parkinson’s) [179, 180].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [180]

Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,936 · see citing works
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works
Astrocytes, from brain glue to communication elements: the revolution continues
Volterra, A., & Meldolesi, J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1722 · Cited by 1,763 · see citing works
Metabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702 · see citing works
Astrocyte activation and reactive gliosis
Pekny, M., & Nilsson, M. (2005) · Glia · doi:10.1002/glia.20207 · Cited by 1,611 · see citing works
Hydrogen peroxide sensing and signaling
Veal, E. A., Day, A. M., & Morgan, B. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.016 · Cited by 1,604 · see citing works
Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)
Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (2000) · Neurochemical Research · doi:10.1023/a:1007677003387 · Cited by 1,368 · see citing works
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352 · see citing works
Hydrogen Peroxide: A Signaling Messenger
Stone, J. R., & Yang, S. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.243 · Cited by 1,175 · see citing works
Astrocyte-mediated control of cerebral blood flow
Takano, T., Tian, G.-F., Peng, W., Lou, N., Libionka, W., Han, X., & Nedergaard, M. (2005) · Nature Neuroscience · doi:10.1038/nn1623 · Cited by 1,137 · see citing works
Protocol for the MPTP mouse model of Parkinson's disease
Jackson-Lewis, V. R., & Przedborski, S. (2007) · Nature Protocols · doi:10.1038/nprot.2006.342 · Cited by 1,118 · see citing works
GFAP in health and disease
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080 · see citing works
Metabolism and function of coenzyme Q
Turunen, M., Olsson, J., & Dallner, G. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.11.012 · Cited by 1,026 · see citing works
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works
Biochemical Functions of Coenzyme Q 10
Crane, F. L. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719063 · Cited by 869 · see citing works
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803 · see citing works
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 802 · see citing works
Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes
Eng, L. F. (1985) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(85)80063-1 · Cited by 737 · see citing works
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 652 · see citing works
Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury
Wilhelmsson, U., Bushong, E. A., Price, D. L., Smarr, B. L., Phung, V., Terada, M., Ellisman, M. H., & Pekny, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602841103 · Cited by 643 · cited 2× · see citing works
“Several studies published in recent years show protective role of reactive astrocytes in traumatic brain injury, spinal cord injury, brain ischemia, and cortical lesion innervation dentate gyrus in mice, highlighting the facts that their function is critical for the survival of neurons (Eng et al., 2000; Hertz and Zie…”
Background
A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606 · see citing works
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597 · see citing works
Signaling at the Gliovascular Interface
Simard, M., Arcuino, G., Takano, T., Liu, Q. S., & Nedergaard, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09254.2003 · Cited by 586 · see citing works
Vitamin E and its function in membranes
Wang, X. (1999) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00008-9 · Cited by 560 · see citing works
Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557 · see citing works
Animal and human studies with the mitochondria‐targeted antioxidant MitoQ
Smith, R. A. J., & Murphy, M. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05627.x · Cited by 553 · see citing works
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
Bhagavan, H. N., & Chopra, R. K. (2006) · Free Radical Research · doi:10.1080/10715760600617843 · Cited by 550 · see citing works
Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease
Beal, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523 · see citing works
Protective Role of Reactive Astrocytes in Brain Ischemia
Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U., Nagai, N., Pardo, A. C., Nodin, C., Ståhlberg, A., Aprico, K., Larsson, K., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600546 · Cited by 505 · see citing works
Motor Coordination and Balance in Rodents
Carter, R. J., Morton, J. P., & Dunnett, S. B. (2001) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0812s15 · Cited by 479 · see citing works
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works
Astrocytic control of glutamatergic activity: astrocytes as stars of the show
Hertz, L., & Zielke, H. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.10.008 · Cited by 470 · see citing works
Astrocytes and the regulation of cerebral blood flow
Koehler, R. C., Roman, R. J., & Harder, D. R. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.005 · Cited by 439 · see citing works
Glia: Initiators and progressors of pathology in Parkinson's disease
Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 423 · see citing works
Functions of Astrocytes and their Potential As Therapeutic Targets
Kimelberg, H. K., & Nedergaard, M. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.006 · Cited by 409 · see citing works
Neuroprotective strategies involving ROS in Alzheimer disease
Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402 · see citing works
Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Dedeoglu, A., Ferrante, K. L., Jenkins, B. G., Hersch, S. M., & Beal, M. F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01592.2002 · Cited by 391 · see citing works
Induction of Glial Fibrillary Acidic Protein Expression in Astrocytes by Nitric Oxide
Brahmachari, S., Fung, Y. K., & Pahan, K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5480-05.2006 · Cited by 390 · see citing works
Localizing NADPH Oxidase–Derived ROS
Ushio‐Fukai, M. (2006) · Science s STKE · doi:10.1126/stke.3492006re8 · Cited by 387 · see citing works
Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease
Maswood, N., Young, J., Tilmont, E. M., Zhang, Z., Gash, D. M., Gerhardt, G. A., Grondin, R., Roth, G. S., Mattison, J. A., Lane, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405831102 · Cited by 383 · see citing works
Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation
Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363 · see citing works
Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases
Mattson, M. P., Pedersen, W. A., Duan, W., Culmsee, C., & Camandola, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07824.x · Cited by 343 · see citing works
Oxidative stress and antioxidant therapy in Parkinson's disease
Ebadi, M., Srinivasan, S. K., & Baxi, M. D. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00029-1 · Cited by 337 · see citing works
The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327 · see citing works
Neuroinflammatory processes in Parkinson's disease
Hirsch, É. C., Hunot, S., & Hartmann, A. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.013 · Cited by 298 · see citing works
Role of glial cells in cerebral ischemia
Nedergaard, M., & Dirnagl, U. (2005) · Glia · doi:10.1002/glia.20205 · Cited by 286 · see citing works
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.
Liu, B., Gao, H., & Hong, J. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6361 · Cited by 285 · see citing works
Differentiation of mouse Neuro 2A cells into dopamine neurons
Tremblay, R. G., Sikorska, M., Sandhu, J. K., Lanthier, P. H., Ribecco‐Lutkiewicz, M., & Bani‐Yaghoub, M. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.11.004 · Cited by 280 · see citing works
Self-citation
Clinical aspects of coenzyme Q10: An update
Littarru, G. P., & Tiano, L. (2009) · Nutrition · doi:10.1016/j.nut.2009.08.008 · Cited by 276 · see citing works
Glial cell influence on the human blood‐brain barrier
Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001) · Glia · doi:10.1002/glia.1104 · Cited by 269 · see citing works
Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging
Hyun, D.-H., Emerson, S. S., Jo, D.-G., Mattson, M. P., & de Cabo, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608008103 · Cited by 267 · see citing works
Functions of coenzyme Q10 in inflammation and gene expression
Schmelzer, C., Lindner, I., Rimbach, G., Niklowitz, P., Menke, T., & Döring, F. (2008) · BioFactors · doi:10.1002/biof.5520320121 · Cited by 265 · see citing works
Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes
Zhu, D., Tan, K. S., Zhang, X., Sun, A. Y., Sun, G. Y., & Lee, J. C.-M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02507 · Cited by 264 · see citing works
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
Beal, M. F., Matthews, R. T., Tieleman, A., & Shults, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01192-x · Cited by 256 · see citing works
Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10
McCarthy, S., Somayajulu, M., Sikorska, M., Borowy-Borowski, H., & Pandey, S. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.019 · Cited by 248 · see citing works
Self-citation
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations
Bhagavan, H. N., & Chopra, R. K. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.003 · Cited by 243 · see citing works
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Kaufmann, P., Thompson, J. L. P., Levy, G., Buchsbaum, R., Shefner, J. M., Krivickas, L. S., Katz, J., Rollins, Y. D., Barohn, R. J., Jackson, C. E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21743 · Cited by 236 · see citing works
Expression and Modulation of an NADPH Oxidase in Mammalian Astrocytes
Abramov, A. Y., Jacobson, J., Wientjes, F. B., Hothersall, J. S., Canevari, L., & Duchen, M. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1632-05.2005 · Cited by 228 · see citing works
DATATOP: A decade of neuroprotective inquiry
Shoulson, I., & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410440724 · Cited by 202 · see citing works
Functions of Mature Mammalian Astrocytes: A Current View
Kimelberg, H. K. (2010) · The Neuroscientist · doi:10.1177/1073858409342593 · Cited by 199 · see citing works
Uptake of Dietary Coenzyme Q Supplement is Limited in Rats
Zhang, Y., Åberg, F. O., Appelkvist, E., Dallner, G., & Ernster, L. (1995) · Journal of Nutrition · doi:10.1093/jn/125.3.446 · Cited by 192 · see citing works
Safety assessment of coenzyme Q 10 (CoQ 10 )
Hidaka, T., Fujii, K., Funahashi, I., Fukutomi, N., & Hosoe, K. (2008) · BioFactors · doi:10.1002/biof.5520320124 · Cited by 187 · see citing works
Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats
Cicchetti, F., Lapointe, N. P., Roberge-Tremblay, A., Saint‐Pierre, M., Jiménez, L. M., Ficke, B. W., & Gross, R. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.018 · Cited by 187 · see citing works
Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10
Somayajulu, M., McCarthy, S., Hung, M.-Y., Sikorska, M., Borowy‐Borowski, H., & Pandey, S. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.021 · Cited by 183 · see citing works
Self-citation
Mitochondrial dysfunction in Parkinson's disease
Schapira, A. H. V. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402160 · Cited by 175 · see citing works
Reduced intravenous glutathione in the treatment of early parkinson's disease
Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00103-0 · Cited by 173 · see citing works
The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking
Hirrlinger, J., & Dringen, R. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.10.003 · Cited by 171 · see citing works
Melatonin and Parkinson's Disease
Mayo, J. C., Sainz, R. M., Tan, D., Antolı́n, I., Rodrı́guez, C., & Reiter, R. J. (2005) · Endocrine · doi:10.1385/endo:27:2:169 · Cited by 162 · see citing works
Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone
Ihara, Y., Namba, R., Kuroda, S., SATO, T. A., & Shirabe, T. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90112-3 · Cited by 161 · see citing works
Therapeutic effects of coenzyme Q 10 (CoQ 10 ) and reduced CoQ 10 in the MPTP model of Parkinsonism
Cléren, C., Yang, L., Lorenzo, B. J., Calingasan, N. Y., Schomer, A. C., Sireci, A. N., Wille, E. J., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05097.x · Cited by 158 · see citing works
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease
Lee, B., Huang, Y., Chen, S., & Lin, P. (2011) · Nutrition · doi:10.1016/j.nut.2011.06.004 · Cited by 157 · see citing works
DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.
Shoulson, I. (1998) · PubMed · Cited by 154 · see citing works
Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP
Seniuk, N. A., Tatton, W. G., & Greenwood, C. E. (1990) · Brain Research · doi:10.1016/0006-8993(90)91055-l · Cited by 153 · see citing works
Randomized, double‐blind, pilot evaluation of intravenous glutathione in Parkinson's disease
Hauser, R. A., Lyons, K. E., McClain, T., Carter, S., & Perlmutter, D. (2009) · Movement Disorders · doi:10.1002/mds.22401 · Cited by 143 · see citing works
Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
Mena, M. A., & de Yébenes, J. G. (2008) · The Neuroscientist · doi:10.1177/1073858408322839 · Cited by 141 · see citing works
Differences in Nigral Neuron Number and Sensitivity to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 Mice
Muthane, U. B., Ramsay, K., Jiang, H., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1058 · Cited by 140 · see citing works
N‐acetylcysteine prevents loss of dopaminergic neurons in the EAAC1−/− mouse
Berman, A., Chan, W., Brennan, A. M., Reyes, R. C., Adler, B. L., Suh, S. W., Kauppinen, T. M., Edling, Y., & Swanson, R. A. (2010) · Annals of Neurology · doi:10.1002/ana.22162 · Cited by 136 · see citing works
A low molecular weight copper chelator crosses the blood–brain barrier and attenuates experimental autoimmune encephalomyelitis
Offen, D., Gilgun‐Sherki, Y., Barhum, Y., Benhar, M., Grinberg, L. N., Reich, R., Melamed, E., & Atlas, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02428.x · Cited by 136 · see citing works
Randomized, Double-Blind Placebo-Controlled Trial of Coenzyme Q10 in Patients with Acute Myocardial Infarction
Singh, R. B., Wander, G. S., Rastogi, A., Shukla, P. K., Mittal, A., Sharma, J. P., Mehrotra, S. K., Kapoor, R., & Chopra, R. K. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007764616025 · Cited by 135 · see citing works
Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 134 · see citing works
Vitamin E and neurodegenerative diseases
Ricciarelli, R., Argellati, F., Pronzato, M. A., & Domenicotti, C. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.01.004 · Cited by 128 · see citing works
The uptake and distribution of coenzyme Q(10)
Miles, M. V. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.02.012 · Cited by 126 · see citing works
The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
Quinn, L. P., Crook, B., Hows, M. E. P., Vidgeon-Hart, M., Chapman, H., Upton, N., Medhurst, A. D., & Virley, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.78 · Cited by 120 · see citing works
Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
Clark, J., Clore, E. L., Zheng, K., Adame, A., Masliah, E., & Simon, D. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012333 · Cited by 118 · see citing works
Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10
Somayajulu‐Nitu, M., Sandhu, J. K., Cohen, J. S., Sikorska, M., Sridhar, T., Matei, A., Borowy‐Borowski, H., & Pandey, S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-88 · Cited by 117 · see citing works
Self-citation
The Existence of a Lysosomal Redox Chain and the Role of Ubiquinone
Gille, L., & Nohl, H. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1649 · Cited by 116 · see citing works
Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q 10 in parkinsonian patients
Shults, C. W., Beal, M. F., Fontaine, D., Nakano, K., & Haas, R. (1998) · Neurology · doi:10.1212/wnl.50.3.793 · Cited by 116 · see citing works
Coenzyme Q10administration and its potential for treatment of neurodegenerative diseases
Beal, M. F. (1999) · BioFactors · doi:10.1002/biof.5520090222 · Cited by 111 · see citing works
Cellular Redox Regulation and Prooxidant Signaling Systems
Linnane, A. W., & Eastwood, H. T. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.008 · Cited by 107 · see citing works
Oral or Intravenous N-Acetylcysteine for Acetaminophen Poisoning?
Prescott, L. F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.09.028 · Cited by 106 · see citing works
Vitamin E therapy in Parkinson's disease
Fariss, M. W. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00158-6 · Cited by 100 · see citing works
A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease
Shults, C. W., Haas, R., & Beal, M. F. (1999) · BioFactors · doi:10.1002/biof.5520090223 · Cited by 91 · see citing works
Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease
Lee, B., Huang, Y., Chen, S., & Lin, P. (2012) · Nutrition · doi:10.1016/j.nut.2011.11.008 · Cited by 90 · see citing works
Review on intermediate filaments of the nervous system and their pathological alterations
Lépinoux-Chambaud, C., & Eyer, J. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1101-1 · Cited by 89 · see citing works
Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2‐derived neurons and astrocytes: Protective effects of coenzyme Q10
Sandhu, J. K., Pandey, S., Ribecco‐Lutkiewicz, M., Monette, R., Borowy‐Borowski, H., Walker, P. R., & Sikorska, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10579 · Cited by 88 · see citing works
Self-citation
Neuroprotection trials in Parkinson's disease: Systematic review
Hart, R. G., Pearce, L. A., Ravina, B. M., Yaltho, T. C., & Marler, J. R. (2008) · Movement Disorders · doi:10.1002/mds.22432 · Cited by 78 · see citing works
N-Acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease
Martı́nez, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02005-9 · Cited by 77 · see citing works
Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
Koppula, S., Kumar, H., More, S. V., Kim, B., Kim, I. S., & Choi, D. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810608 · Cited by 74 · see citing works
Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection
Tang, P., Miles, M. V., Miles, L., et al. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.12.002 · Cited by 71 · see citing works
Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease
Muthukumaran, K., Leahy, S., Harrison, K., Sikorska, M., Sandhu, J. K., Cohen, J. S., Keshan, C., Lopatin, D., Miller, H., Borowy‐Borowski, H., et al. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-21 · Cited by 68 · see citing works
Self-citation
Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells
Naderi, J., Somayajulu‐Nitu, M., Mukerji, A., Sharda, P. R., Sikorska, M., Borowy‐Borowski, H., Antonsson, B. E., & Pandey, S. (2006) · APOPTOSIS · doi:10.1007/s10495-006-8417-4 · Cited by 66 · see citing works
Self-citation
Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study
Sharma, N., & Nehru, B. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.214 · Cited by 66 · see citing works
The Role of Astroglia on the Survival of Dopamine Neurons
Mena, M. A., de Bernardo, S., Casarejos, M. J., Canals, S., & Rodríguez‐Martín, E. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:3:245 · Cited by 65 · see citing works
Clinical trials of coenzyme Q10 in neurological disorders
Shults, C. W., & Haas, R. (2005) · BioFactors · doi:10.1002/biof.5520250113 · Cited by 62 · see citing works
Reactive Astrocytes Are Key Players in Nigrostriatal Dopaminergic Neurorepair in the Mptp Mouse Model of Parkinson’s Disease: Focus on Endogenous Neurorestoration
L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., & Marchetti, B. (2013) · Current Aging Science · doi:10.2174/1874609811306010007 · Cited by 59 · see citing works
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: Evidence for glial response to injury
Reinhard, J. F., Miller, D. B., & O'Callaghan, J. P. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90665-9 · Cited by 57 · see citing works
The coenzyme Q10 status of the brain regions of Parkinson’s disease patients
Hargreaves, I. P., Lane, A., & Abou‐Sleiman, P. M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.069 · Cited by 56 · see citing works
Effects of Coenzyme Q10 on TNF‐α secretion in human and murine monocytic cell lines
Schmelzer, C., Lorenz, G., Lindner, I., Rimbach, G. H., Niklowitz, P., Menke, T., & Döring, F. (2007) · BioFactors · doi:10.1002/biof.5520310104 · Cited by 54 · see citing works
Oxidative Stress to Dopaminergic Neurons as Models of Parkinson's Disease
GILLE, G., HUNG, S., REICHMANN, H., & RAUSCH, W. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.066 · Cited by 53 · see citing works
Coenzyme Q10 (Ubiquinol-10) Supplementation Improves Oxidative Imbalance in Children With Trisomy 21
Miles, M. V., Patterson, B. J., Chalfonte-Evans, M., Horn, P. S., Hickey, F. J., Schapiro, M. B., Steele, P. E., Tang, P., & Hotze, S. L. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.08.003 · Cited by 52 · see citing works
The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons
Mouton, P. R., Kelley-Bell, B., Tweedie, D., Spangler, E. L., Perez, E., Carlson, O. D., Short, R. G., de Cabo, R., Chang, J. P., Ingram, D. K., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.025 · Cited by 47 · see citing works
Prolonged coenzyme Q10 treatment in Down syndrome patients, effect on DNA oxidation
Tiano, L., Padella, L., Santoro, L., Carnevali, P., Principi, F., Brugè, F., Gabrielli, O., & Littarru, G. P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.025 · Cited by 43 · see citing works
Glial Cell Response: A Pathogenic Factor in Parkinson's Disease
Wu, D. C., Tieu, K., Cohen, O. S., Choi, D., Vila, M., Jackson-Lewis, V. R., Teismann, P., & Przedborski, S. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100905 · Cited by 37 · see citing works
Unique Technology for Solubilization and Delivery of Highly Lipophilic Bioactive Molecules
Borowy‐Borowski, H., Sodja, C., Docherty, J. C., et al. (2004) · Journal of drug targeting · doi:10.1080/10611860412331285233 · Cited by 37 · see citing works
Self-citation
Recent Updates in Redox Regulation and Free Radical Scavenging Effects by Herbal Products in Experimental Models of Parkinson’s Disease
Koppula, S., Kumar, H., More, S. V., Lim, H.-W., Hong, S.-M., & Choi, D. (2012) · Molecules · doi:10.3390/molecules171011391 · Cited by 37 · see citing works
The 21st Century Form of Vitamin E - Tocotrienol
Bardhan, J., Chakraborty, R., & Raychaudhuri, U. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796957472 · Cited by 33 · see citing works
γ-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than α-tocopherol in mouse brain
Itoh, N., Masuo, Y., Yoshida, Y., Cynshi, O., Jishage, K., & Niki, E. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.028 · Cited by 31 · see citing works
NADPH oxidase produces reactive oxygen species and maintains survival of rat astrocytes
Liu, Q., Kang, J., & Zheng, R. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1171 · Cited by 30 · see citing works
Derivatised α‐tocopherol as α CoQ10 carrier in a novel water‐soluble formulation
Sikorska, M., Borowy‐Borowski, H., Zurakowski, B., et al. (2003) · BioFactors · doi:10.1002/biof.5520180220 · Cited by 28 · see citing works
Self-citation
Seasonal variation of Co-enzyme Q10 content in pelagic fish tissues from Eastern Quebec
Souchet, N., & Laplante, S. (2007) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2006.09.004 · Cited by 27 · see citing works
Identification of ataxia‐associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in transmitochondrial cybrids
Sikorska, M., Sandhu, J. K., Simon, D. K., Pathiraja, V., Sodja, C., Li, Y., Ribecco‐Lutkiewicz, M., Lanthier, P. H., Borowy‐Borowski, H., Upton, A. R. M., et al. (2009) · Muscle & Nerve · doi:10.1002/mus.21355 · Cited by 27 · see citing works
Self-citation
CNS neurons express two distinct plasma membrane electron transport systems implicated in neuronal viability
Wright, M. V., & Kuhn, T. B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01176.x · Cited by 25 · see citing works
The 5-HT2A Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate
Ansah, T. A., Ferguson, M. C., & Nayyar, T. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00048 · Cited by 22 · see citing works
Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain
Ren, Y., Nishida, Y., Yoshimi, K., Yasuda, T., Jishage, K., Uchihara, T., Yokota, T., Mizuno, Y., & Mochizuki, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03994.x · Cited by 19 · see citing works
Effects of glutathione depletion on the viability of human NT2-derived neuronal and astroglial cultures
BYRD, A. S., Sikorska, M., Walker, P. R., et al. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x05000207 · Cited by 17 · see citing works
Self-citation
Vitamin E therapy in Parkinson's disease.
Sa, F., Sanchez-Ramos, & Wj, W. (1990) · PubMed · Cited by 15 · see citing works
The Evidence for Disease Modification in Parkinson's Disease
Lew, M. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.620194 · Cited by 11 · see citing works
Analysis of Coenzyme Q10 Content in Human Plasma and Other Biological Samples
Graves, S. S., Sikorska, M., Borowy‐Borowski, H., et al. (2003) · Humana Press eBooks · doi:10.1385/0-89603-472-0:353 · Cited by 10 · see citing works
Self-citation

Flagged first, then by citations

Sorted by citations

Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works
Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases
Gutierrez-Mariscal, F. M., Arenas-de Larriva, A. P., Limia-Perez, L., Romero-Cabrera, J. L., Yubero-Serrano, E. M., & López-Miranda, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217870 · Cited by 190 · see citing works
1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
Ortíz de Zárate, A., Pérez-Torralba, M., Bonet Isidro, I., López, C., Claramunt, R. M., Martínez-Casanova, D., Sánchez-Vera, I., Jiménez-González, J., & Lavandera, J. L. (2021) · Antioxidants · doi:10.3390/antiox10101584 · Cited by 11 · see citing works

Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases
Beal, M. F., & Matthews, R. T. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00024-1 · Cited by 58 · see citing works
Neuroprotective Effect of Coenzyme Q10 in Hippocampal Injury in Balb/c Mouse
Rigi, S., Sakhaei, A., Asl, A. N., et al. (2014)
Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10
Filipiak, K. J., Surma, S., Romańczyk, M., & Okopień, B. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9050161 · Cited by 5 · see citing works
Administration of coenzyme Q10 to a diabetic rat model: changes in biochemical, antioxidant, and histopathological indicators
Peter, J. S., Shalini, M., Giridharan, R., Basha, K. S., Baskaran, U. L., & Prince, S. E. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00752-z · Cited by 3 · see citing works
[Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status].
Menke, T. (2008) · PubMed · Cited by 2 · see citing works

Authors: Sikorska, M., Lanthier, P., Miller, H., Beyers, M., Sodja, C., Zurakowski, B., Gangaraju, S., Pandey, S., & Sandhu, J. K.
Affiliations: National Research Council Canada (CA)
University of Windsor (CA)
Corresponding author: Sandhu, Jagdeep K.
ORCID: Gangaraju, Sandhya
Pandey, Siyaram
Sandhu, Jagdeep K.
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 2014-10
Volume: 35
Issue: 10
Pages: 2329-2346
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/j.neurobiolaging.2014.03.032
PMC: PMC4892899
OpenAlex: W2115314563
Cited by: 70
References: 128
Citations by year: 2026: 3 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 14 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 7 · 2015: 4 · 2014: 2
FWCI: 2.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
NPARC (acceptedVersion)
Funders: Michael J Fox Foundation
National Research Council Canada
Canadian Institute for Health Research
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: coenzyme Q10, Parkinson's disease, MPTP-induced neurotoxicity, neuroprotection, dopaminergic neurons, brain penetration, antioxidants, adjuvant therapy, astrocyte activation, striatal dopamine, motor function, neurodegeneration, drug delivery, bioavailability, dose-response relationship, astrocytes
MeSH terms: Animals, Antioxidants, Astrocytes, Chemistry, Pharmaceutical, Disease Models, Animal, Male, Mice, Inbred C57BL, Micelles, Oxidation-Reduction, Parkinson Disease, Ubiquinone, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroprotective Agents, Nanoparticles, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks